J. Chao

885 citations

46 papers · 689 indexed · h-index 8

Impact in

Genetics top 5%
- Inflammatory Bowel Disease
Epidemiology top 10%
- Microscopic Colitis
- Autoimmune and Inflammatory Disorders

Papers in

Dermatology 9
- Dermatology and Skin Diseases 9
Genetics 28
- Inflammatory Bowel Disease 28

Co-authors: Parvez Mulani Andrew P. Yu Jiuyong Xie Russell D. Cohen Eric Q. Wu Douglas C. Wolf William J. Sandborn Anne Robinson
Journals: Journal of Crohn s and Colitis (10 papers)Gut (6 papers)Alimentary Pharmacology & Therapeutics (4 papers)Journal of Investigative Dermatology (4 papers)The American Journal of Gastroenterology (4 papers)
Partner nations: United States France Germany

In The Last Decade

J. Chao

43 papers receiving 676 citations

Peers

Countries citing papers authored by J. Chao

Since Specialization

Citations

This map shows the geographic impact of J. Chao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Chao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Chao more than expected).

Fields of papers citing papers by J. Chao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Chao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Chao. The network helps show where J. Chao may publish in the future.

Co-authors

The 25 scholars most cited alongside J. Chao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. Chao Line = papers co-authored together J. Chao links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	147 Development and validation of a caregiver-reported numeric rating scale for measuring pruritus in children aged 6 months to <6 years with atopic dermatitis Journal of Investigative Dermatology ·Amy S. Paller, Elaine C. Siegfried, S.E. Marrón, M. Clark, Dana DiBenedetti, Lauren Nelson, J. Chao, Ashish Bansal, Yiping Sun, Chien‐Chia Chuang, Zhenxun Wang	2022	1
2	Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase III trials British Journal of Dermatology ·Jonathan I. Silverberg, Eric L. Simpson, Marius Ardeleanu, Diamant Thaçi, S. Barbarot, Jerry Bagel, Z. Chen, Laurent Eckert, J. Chao, Andrew Korotzer, E. Rizova, Ana B. Rossi, Yuan Lü, E. Granz, Thomas Hultsch, Gianluca Pirozzi, Bolanle Akinlade	2019	44
3	243 Real world systemic corticosteroid (SCS) utilization patterns and costs in adult patients with atopic dermatitis (AD) Journal of Investigative Dermatology ·April W. Armstrong, Wenhui Wei, Raymond Miao, M. PATEL, Adam Huang, Liping Wang, J. Chao	2017	0
4	204 A real-world study evaluating adeQUacy of Existing Systemic Treatments for patients with moderate-to-severe Atopic Dermatitis (AD-QUEST): Baseline treatment patterns and unmet needs assessment Journal of Investigative Dermatology ·Wenhui Wei, E. Rosenstock, Michael Andria, Valery Walker, J. Chao, 久美松村, محسوب عبدالقادر الضوي, Z. Chen, Serhii Vasylovych Chyrva, John White, Jonathan I. Silverberg	2017	1
5	244 Risk of contraindication and drug-drug interaction (DDI) with use of systemic immunosuppressants (IMMs) in adult patients with atopic dermatitis (AD) Journal of Investigative Dermatology ·April W. Armstrong, Wenhui Wei, Itanielly Dantas Silveira Cruz, Dendy Macaulay, 祥夫須藤, E.Q. Wu, Drishti Shah, J. Chao	2017	1
6	P353. Are we under-recognizing skewed thiopurine metabolism in IBD patients? Routine thiopurine metabolite measurement yields clinical benefit at 12 months: A retrospective observational study. Journal of Crohn s and Colitis ·Anissa Ermasari, Yifeng Xiao, Rachel Grafton, Paul Leach, M Kornapp, Watson Ng, Susan J. Connor, Peter A. Bampton, Jane M. Andrews, David T. Rubin, Martha Skup, Scott J. Johnson, J. Chao, Allan Gibofsky, (unknown), (unknown)	2015	1
7	Impact of non-medical switching on Healthcare costs: a claims database analysis Value in Health ·Umme Sarhad Khan Yousafzai, Martha Skup, Jenny J. Lin, J. Chao	2015	9
8	SAT0139 Analysis of Outcomes After Non-Medical Switching of Anti–Tumor Necrosis Factor Agents Annals of the Rheumatic Diseases ·Allan Gibofsky, Martha Skup, Scott J. Johnson, J. Chao, Daniel S. Rubin	2015	2
9	Cost-effectiveness of adalimumab for the treatment of moderately to severely active ulcerative colitis in Canada Value in Health ·Subrata Ghosh, Olivier Desjardins, Martha Skup, Wanda Puspita Anggraeny, Min Yang, Hongbo Yang, Asgari Reza, Yanjun Bao, J. Chao	2014	2
10	P311 Adalimumab treatment is associated with improved quality of life in pediatric Crohn's disease Journal of Crohn s and Colitis ·哲也平林, G. Veereman‐Wauters, Wallace Crandall, Mutiara Timbuleng, A. Lazar, Mei Yang, Martha Skup, Abolfazl Fattah, J. Chao, Roopal Thakkar, Dipa Chauhan And M. Daniel	2013	1
11	PWE-254 Impact of induction dosing on maintenance outcome with adalimumab in Crohn's disease Gut ·J F Colombel, P. J. Rutgeerts, William J. Sandborn, Walter Reinisch, Edward V. Loftus, Jackson Tang, P Pollack, Mei Yang, Saagar Patel, B Huang, J. Chao, Parvez Mulani	2012	3
12	PWE-253 Adalimumab improves health-related quality of life for 52 weeks in patients with ulcerative colitis: Abstract PWE-253 Table 1 Gut ·William J. Sandborn, Gert Van Assche, Roopal Thakkar, A. Lazar, Martina Kron, Mei Yang, Saagar Patel, J. Chao, Parvez Mulani	2012	2
13	PGI20 Cost-Effectiveness of Adalimumab for Treatment of Crohn's Disease in Germany Value in Health ·Min Yang, Mei Yang, Martha Skup, Zheng‐Yi Zhou, 伊藤信二, Marcelo Wolff, Parvez Mulani, J. Chao	2012	1
14	Achievement of early deep remission is associated with lower rates of weekly dosing for adalimumab-treated patients with crohn's disease: data from extend: Table 1 Gut ·W. Sandborn, J F Colombel, Kathleen G. Lomax, P Pollack, Roopal Thakkar, A. Camez, Lijuan Hua, Mei Yang, J. Chao, Parvez Mulani	2011	10
15	Markov model projection of remission status for early versus delayed step-up adalimumab use in moderate to severe crohn's disease Gut ·Edward V. Loftus, J. Chao, Mei Yang, P Pollack, G. Groppo, Roopal Thakkar, Parvez Mulani	2011	1
16	Achievement of early deep remission predicts better long-term outcomes for adalimumab-treated patients with Crohn's disease Inflammatory Bowel Diseases ·William J. Sandborn, J F Colombel, P. Rutgeerts, Mei Yang, Jean Palomeque-Jaramillo, P Pollack, Roopal Thakkar, A. Camez, Mu Ming, J. Chao, Parvez Mulani	2011	1
17	Systematic review: the costs of ulcerative colitis in Western countries Alimentary Pharmacology & Therapeutics ·Russell D. Cohen, Andrew P. Yu, Eric Q. Wu, Jiuyong Xie, Parvez Mulani, J. Chao	2010	226
18	The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn’s disease who failed prior infliximab therapy Alimentary Pharmacology & Therapeutics ·Simon Lichtiger, F. Shafer, Douglas C. Wolf, D. H. Present, Arielle G. Bensimon, E.Q. Wu, Andrew P. Yu, 悠风可见, J. Chao, Parvez Mulani, Kathleen G. Lomax, Jeffrey D. Kent	2010	149
19	P069 - The CARE trial: adalimumab improves work productivity and quality of life in patients with Crohn's disease Journal of Crohn s and Colitis ·Edouard Louis, Robert Löfberg, Walter Reinisch, Ava E Archey, Parvez Mulani, J. Chao	2009	1
20	Impact of Steroid Discontinuation on Health Care Resource Utilization in Crohnʼs Disease The American Journal of Gastroenterology ·T. Hreus, Edward V. Loftus, MA Kamm, J. Chao, Parvez Mulani	2007	1

About J. Chao

J. Chao is a scholar working on Dermatology, Genetics, Epidemiology, Speech and Hearing and Rheumatology, having authored 46 papers that have together received 689 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (28 papers), Microscopic Colitis (24 papers), Dermatology and Skin Diseases (9 papers), Eosinophilic Esophagitis (8 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers), Biosimilars and Bioanalytical Methods (5 papers), Asthma and respiratory diseases (4 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). The work is most often cited by research in Genetics (546 citations), Epidemiology (425 citations), Immunology and Allergy (52 citations), Gastroenterology (40 citations) and Dermatology (62 citations). J. Chao has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Parvez Mulani, Andrew P. Yu, Jiuyong Xie, Russell D. Cohen, Eric Q. Wu, Douglas C. Wolf, William J. Sandborn, Anne Robinson, Kathleen G. Lomax and E.Q. Wu. Their work appears in journals such as Journal of Crohn s and Colitis, Gut, Alimentary Pharmacology & Therapeutics, Journal of Investigative Dermatology and The American Journal of Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact